摘要
The prostaglandin derivatives have been approved for marketing for the last 6 years and have been shown to be more effective in lowering IOP than most previously available drugs. The distinguishing characteristics of the prostaglandin derivatives include a unique mechanism of action, once-daily dosing and the lack of systemic side effects. The prostaglandin derivatives that
出处
《国际眼科杂志》
CAS
2003年第1期120-120,共1页
International Eye Science
